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ABSTRACT
Objectives: The sedentary lifestyle, physical inactivity, and unhealthy diet of Malaysian female have become important contributing factors to the 
rise of obesity. Studies on pulmonary function in relation to obesity are very few in Malaysia. Therefore, the study was aimed to evaluate the effect of 
obesity on pulmonary functions among young adult healthy female students of Shah Alam, Malaysia.
Methods: A cross-sectional comparative study was conducted in a total of 100 (50 obese and 50 non-obese) adult non-smoker healthy female 
students aged 18–25 years. Forced vital capacity (FVC), forced expiratory volume in 1 sec (FEV1), FEV1 as a percentage of FVC (FEV1/FVC%), maximum 
midexpiratory flow rate (FEF 25–75%), and peak expiratory flow rate (PEFR) were measured using a computerized spirometer. Body weight, height, 
waist circumference (WC), and hip circumference (HC) were measured.
Results: The mean FVC (L), FEV1 (L), FEV1/FVC ratio, FEF 25–75% (L/s), and PEFR (L/s) of obese group were marginally lower than non-obese 
control group, but the differences were not statistically significant. WC and waist–hip ratio exhibited significant (p<0.05) inverse correlation with all 
pulmonary function measurements except FEV1/FVC%. However, body mass index had no significant correlation with any spirometric variables in 
studied obese females.
Conclusion: There was no significant effect of obesity on pulmonary functions in the studied Malaysian females. However, abdominal obesity had 
more impact on the impairment of pulmonary functions than overall relative obesity.
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INTRODUCTION
Prevalence of overweight and obesity has reached epidemic levels in 
Malaysia. The rapid economic development which has taken place in 
Malaysia in the last quarter of the 20th century, results in nutrition 
transition which has become one of the predominant factor for the 
prevalence of increased obesity in Malaysia [1]. Malaysia has recently 
been ranked second highest in East and Southeast Asia in terms of being 
overweight [2]. The sedentary lifestyle and unhealthy diet of Malaysian 
have become important contributing factors to the rise of obesity. 
Based on the report of National Health and Morbidity Surveys in 2015, 
the prevalence of overweight and obesity among Malaysian adults aged 
18 years and above has increased from 29.4% and 15.1% in 2011 [3] to 
30.0% and 17.7% in 2015 [4].
Obesity has been associated with many common non-communicable 
cardiovascular and metabolic diseases such as hypertension, diabetes, 
and hyperlipidemia [5]. However, obese people may have higher 
risk of respiratory impairments also. They often feel shortness of 
breath, particularly during exercise, even if they have no pulmonary 
diseases [6]. There are several respiratory complications due to obesity. 
Major complications are lowering of respiratory muscle endurance, 
chest wall compliance, and elevated work of breathing. Expiratory 
reserve volume and functional residual capacity are two most common 
lung function test abnormalities in obesity [7] which also leads to 
decreased total respiratory compliance [8].
The pulmonary function tests (PFTs) are non-invasive tests which help 
to diagnose patients with obstructive and restrictive lung diseases. 
Pulmonary function parameters are influenced by both relative obesity 
and body fat (BF) distribution. Based on the excess BF distribution, 
obesity can be categorized as central pattern (which is common in men) 
and peripheral pattern (common in women). Body mass index (BMI) 
is a measure of relative adiposity, whereas waist circumference (WC) 
and waist–hip ratio (WHR) are considered as a measure of central 
obesity. Studies have shown that both obesity itself and the pattern 
of BF distribution have an independent effect on ventilatory functions 
[9]. Most of the previous studies on pulmonary function impairment 
in relation to obesity have used BMI as an obesity indicator [10,11]. 
However, the abdominal obesity markers are better predictors of 
pulmonary function than BMI [12]. Studies on pulmonary function in 
relation to obesity are scanty in Malaysia. Our recent study Bhattacharje 
et al. [13] showed that obesity has adverse effect on dynamic lung 
function parameters in young non-smoker healthy Malaysian male, 
and central obesity has more impact on the impairment of pulmonary 
functions than overall relative obesity. Therefore, the present study 
was aimed to evaluate the effect of obesity on dynamic lung function 
parameters as well as to identify the association of both relative and 
abdominal obesity indicators with dynamic pulmonary function 
parameters among young non-smoker female university students 
of Shah Alam, Malaysia. We hypothesized that upper BF is a better 
predictor of reduced pulmonary function than total body adiposity.
METHODS
This cross-sectional study was conducted in the Human Physiology 
Laboratory of International Medical School, Management, and Science 
University, Shah Alam, Malaysia. Subjects with BMI >30 kg/m2 were 
defined as obese [14]. 50 such obese female were identified from the 
student population of the management and Science University, Shah 
Alam Campus, Malaysia. An identical number (50) of age-matched 
non-obese with BMI between 18.50 and 24.99 kg/m2 was taken as a 
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control group. Therefore, a total of 100 (50 obese and 50 non-obese) 
non-smoker, healthy young female subjects were selected for the study. 
The study population belonged to the age group of 18–25 years and 
with similar socioeconomic backgrounds.
Each subject filled up one questionnaire [15] to record their personal 
demographic data, health status, and consent to participate in the study. 
The experimental protocol was explained to all the participants. Each 
subject signed the written informed consent form.
Exclusion criteria
Subject with symptoms of illness such as fever, cough, abdominal 
pain, any history of pulmonary diseases, anxious, apprehensive, doing 
regular exercise, and uncooperative ones was excluded from the study.
Anthropometric measurements
The body weight was measured using a balanced beam scale with 
an accuracy of ±0.1 kg with the subject wearing minimum clothing, 
whereas body height was measured with the measuring rod attached 
to the balanced beam with an accuracy of ±0.50 cm. WC was measured 
as the smallest circumference between the ribs and the iliac crest to the 
nearest 0.1 cm, while the participant was standing with the abdomen 
relaxed, at the end of normal expiration. Hip circumference (HC) was 
recorded as the maximum circumference between the iliac crest and 
the pubic symphysis. WHR was calculated by dividing WC by HC.
Pulmonary function measurements
The dynamic pulmonary functions were recorded using a computerized 
spirometer (Spirobank II MIR, Del Maggiolino 125, 00155 Roma, 
Italy). The spirometer was calibrated daily using a calibration syringe 
of 2 L. The parameters measured were forced vital capacity (FVC), 
forced expiratory volume in 1 sec (FEV1), FEV1 as a percentage 
of FVC (FEV1%), midexpiratory flow rate (FEF 25–75%), and 
peak expiratory flow rate (PEFR). All the measurements were conducted 
in standing posture with nose clipped [16]. These tests were recorded 
at noon before lunch, as expiratory flow rates are highest at noon [17]. 
Three satisfactory efforts were recorded for each volunteer with at 
least 5 min rest between the consecutive trials as per the standard 
norm [18]. All the anthropometric measurements and pulmonary 
function measurements were recorded in one sitting on the same day 
for each subject.
Statistical analysis
Student’s t-test was performed to test the significance of differences 
between mean values of obese and control group. Pearson’s product 
moment correlation (r) was adopted to test the relationship of 
anthropometric parameters with the dynamic pulmonary function 
measurements in both obese and control group. The level of statistical 
significance was set at p<0.05.
RESULTS
Table 1 compares the demographic and anthropometric variables of 
the obese and control groups. The mean BMI of the obese group was 
32.3±5.23 kg/m2 compared to the control group’s 22.81±2.27 kg/m2 
and the difference was significant (p<0.001). The mean age of the obese 
and control groups was 20.6±2.08 and 21.24±2.18 years, respectively, 
suggesting that the subjects of both the studied groups 
(obese and non-obese) fall under same age. The mean body weight, 
WC, and HC of the obese students were significantly (p<0.001) higher 
compared to control group with same age, whereas WHR had no 
significant difference.
The comparison of dynamic pulmonary function parameters of the 
obese and non-obese has been depicted in Table 2.
The mean FEV1/FVC ratio of obese subjects was 89.04±12.71%, which 
was marginally lower than non-obese control group where the mean 
was 95.29±7.32% (Fig. 1), but the difference was not statistically 
significant (p=0.06).
The mean FVC (L), FEV1 (L), FEF 25–75% (L/s), and PEFR (L/s) of obese 
subjects were lower than non-obese control group, but the differences 
were not significant (Fig. 2).
Table 3 depicts the correlation between different anthropometric 
obesity markers with dynamic lung function measurements in obese 
female. Based on correlation coefficient values and p values, WC and 
WHR had significant inverse correlation with FVC, FEV1, FEF 25–75%, 
and PEFR in obese female, indicating the impairments of pulmonary 
function with increasing central obesity. However, BMI, which is the 
indicator of relative or overall obesity had no significant association 
with any dynamic pulmonary functions.
Table 4 presents the correlation between different anthropometric 
obesity indices with dynamic lung function measurements in non-obese 
normal weight female. In normal weight control group, BMI exhibited 
a significant negative correlation with FEV1/FVC%, FEF 25–75%, and 
Fig. 1: Comparison of forced expiratory volume 1/forced vital 
capacity ratio between obese and non-obese (control group) 
healthy female of Shah Alam, Malaysia
Table 1: Physical and anthropometric characteristics of obese 






Obese (n=50) Non-obese (n=50)
Age (years) 20.68±2.08 21.24±2.18 0.329
Height (cm) 160.24±8.07 160.20±6.02 0.98
Weight (kg) 83.24±16.62 58.64±7.20 <0.001**
BMI (kg/m2) 32.31±5.23 22.81±2.27 <0.001**
WC (cm) 100.68±11.91 83.32±9.49 <0.001**
HC (cm) 130.04±13.71 103.00±8.83 <0.001**
WHR 0.78±0.05 0.81±0.06 0.04
**Highly significant P<0.001, BMI: Body mass index, WC: Waist circumference, 
HC: Hip circumference, WHR: Waist–hip ratio
Table 2: Comparison of dynamic lung function parameters 
between obese and non-obese (control group) healthy young 
female of Shah Alam, Malaysia
PFT parameters Obese (n=50) Non-obese (n=50) Significance
Mean±SD Mean±SD p values
FVC (L) 2.19±0.51 2.22±0.45 0.812 NS
FEV1(L) 1.95±0.58 2.11±0.46 0.23 NS
FEV1/FVC (%) 89.04±12.71 95.29±7.32 0.06 NS
FEF 25–75% (L/s) 2.78±1.30 3.13±0.98 0.319 NS
PEFR (L/s) 3.51±1.75 4.22±1.51 0.18 NS
Student’s t-test was used to compare the significance of difference between 
means; NS: Not significant, FVC: Forced vital capacity, FEV1: Forced expiratory 
volume in 1 s, FEV1/FVC: FEV1 as percentage of FVC, FEF 25–75%: Maximum 
midexpiratory flow rate, PEFR: Peak expiratory flow rate
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PEFR, whereas WHR had significant inverse correlation with FVC and 
FEV1. However, HC exhibited a significant positive correlation with 
FEV1 and FEF 25–75% in normal-weight control subjects.
DISCUSSION
In the global context, many countries, especially in Asia, obesity has 
become a leading health issue. Urbanization has positive significant 
impact on the prevalence of obesity [19]. Physical inactivity is the 
important contributing factor for the prevalence of obesity among 
young adult female students [20]. One recent study by San et al. [21] 
revealed that unhealthy food habit such as intake of frequent fast 
food is associated with the prevalence of obesity among Malaysian 
adult. Many physiological factors affect lung function. The effect of 
age, gender, ethnicity, and smoking status on lung function has been 
confirmed [22,23]. The effects of obesity on spirometric values are not 
consistent. Some studies showing no effects [24,25] and some other 
studies showing significant effects [7,26-28]. By this study, we tried to 
evaluate the effect of obesity on different dynamic pulmonary functions 
among Malaysian non-smoker healthy adult female university students 
by comparing lung function of the obese (BMI >30 kg/m2) to their age 
matching normal weight control group (BMI 18.5–24.99 kg/m2). Our 
study showed that the mean FVC (L), FEV1 (L), FEV1/FVC ratio, FEF 
25–75% (L/s), and PEFR (L/s) of obese subjects were somewhat lower 
than non-obese control group, but the differences were not statistically 
significant. This may suggest that obesity has no such adverse effect 
on dynamic lung function parameters in the studied Malaysian 
females. Our observation was supported by a study by Al Ghobain [26] 
conducted on Saudi population where he showed that there were no 
significant differences between the obese and non-obese subjects in 
FEV1, FVC, FEV1/FVC ratio, and FEF 25–75%. Carey et al. [29] showed 
a reduction in FEV1 but not FVC in obese individual, whereas similar 
other studies [30,31] showed a decline in both FEV1 and FVC in obese 
individuals. This discrepancy between studies regarding the effect of 
obesity on pulmonary function may be explained by the wide variations 
in ethnicity of different population in PFT values, or this may be a result 
of methodological differences in these studies.
Most of the previous studies reported an inverse relation between 
respiratory function and various indices of obesity [10,29-33]. Central 
obesity (abdominal and thoracic fat) is likely to have direct effects on the 
pulmonary function, whereas peripheral obesity (the fat on the hips and 
thighs) would be less likely to have any direct mechanical effect on the 
lungs. In our study, we investigated the association between adiposity 
markers with pulmonary function measurements in non-smoker 
healthy young university girls. In obese girls, WC and WHR exhibited 
strong significant inverse correlation with all pulmonary function 
measurements except FEV1/FVC%, whereas BMI had no significant 
association with any pulmonary function parameters, suggesting 
that central obesity has more impact on impairment of dynamic 
lung function than overall relative obesity. Our findings support the 
hypothesis that abdominal adiposity markers have better explanatory 
power than total body adiposity measured as BMI according to p value 
significance and the correlation coefficient values. Similar findings 
were observed by Banerjee et al. [11] where there was no significant 
association between BMI and lung function parameters (FVC, FEV1, 
FEV1/FVC, and FEF 25–75%) in obese male non-asthmatic subjects in 
India. Our results were consistent with finding by Chen et al. [34] where 
WC was inversely associated with FVC and FEV1. In our study, we found 
that central obesity markers are better predictor of lung function than 
BMI, which is supported by a study [35] in Western New York where 
they found that WC was a better predictor of pulmonary function than 
BMI. BMI is not an ideal measure for obesity as a predictor of pulmonary 
function because of two reasons. First, a higher BMI value for non-obese 
persons than for obese persons may result from more muscle mass than 
fat mass (FM). Second, BMI is calculated from body weight and height, 
which are correlated with body size - the larger the body size, the 
Fig. 2: Comparison of dynamic lung function parameters between 
obese and non-obese (control group) healthy female of Shah Alam, 
Malaysia
Table 3: Correlation of anthropometric obesity indices with pulmonary function measurements in obese female (n=50)
PFT parameters BMI (kg/m2) WC (cm) HC (cm) WHR
r values p values r values p values r values p values  r values p values
FVC (L) 0.08! 0.58 -0.50** 0.00 -0.05! 0.73 -0.35* 0.01
FEV1 (L) -0.07! 0.62 -0.46** 0.00 -0.01! 0.94 -0.35* 0.01
FEV1/FVC (%) -0.25! 0.07 -0.08! 0.58 0.06! 0.67 -0.11! 0.44
FEF 25–75% (L/s) -0.19! 0.18 -0.32* 0.02 0.03! 0.83 -0.28* 0.04
PEFR (L/s) -0.23! 0.10 -0.28* 0.04 0.08! 0.58 -0.29* 0.04
**Highly significant P<0.001, *mild significant P<0.05, !: Not significant, r: Correlation coefficient, FVC: Forced vital capacity, FEV1: Forced expiratory volume in 1 s, 
PEFR: Peak expiratory flow rate
Table 4: Correlation of anthropometric obesity indices with pulmonary function measurements in non-obese female (n=50)
PFT parameters BMI (kg/m2) WC (cm) HC (cm) WHR
r values p values r values p values r values p values r values p values
FVC (L) 0.04! 0.78 -0.03! 0.83 0.25! 0.07 -0.34* 0.01
FEV1 (L) -0.12! 0.40 0.06! 0.67 0.32* 0.02 -0.28* 0.04
FEV1/FVC (%) -0.50** 0.00 0.23! 0.10 0.23! 0.10 0.09! 0.53
FEF25-75% (L/s) -0.28* 0.04 0.20! 0.16 0.44** 0.00 -0.17! 0.23
PEFR (L/s) -0.35* 0.01 0.04! 0.78 0.23! 0.10 -0.19! 0.18
**Highly significant P<0.001, * mild significant P<0.05, !: Not significant, r: Correlation coefficient, FVC: Forced vital capacity, FEV1: Forced expiratory volume in 1 s, 
PEFR: Peak expiratory flow rate
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greater the PFT variables. The impairment of pulmonary function by 
abdominal obesity may be explained by some proposed mechanisms. 
One possible mechanism for the association of abdominal adiposity 
and pulmonary function is a mechanical limitation of chest expansion 
during the FVC maneuver. Increased abdominal mass may impede 
the descent of the diaphragm and increase thoracic pressure [36]. 
Our findings have similarity with findings of Saxena et al. [12] where 
they showed abdominal adiposity markers such as WHR and WC had 
strong negative correlation with FEV1. Pouliot et al. also showed that 
abdominal adiposity markers have much better explanatory power 
than total body adiposity measured as BMI [37].
Limitation
There are few limitations in our study. A bigger sample size would have 
given more concrete evidence. In our study, we have only investigated 
the dynamic lung volumes; we did not examine static lung volumes. FM 
and BF% and conicity index (CI) were not determined as measure of 
obesity.
CONCLUSION
Our study showed that there was no significant difference in dynamic 
pulmonary functions among obese and normal weight non-smoker 
healthy studied females. This may suggest that obesity has no such 
adverse effect on dynamic lung function parameters on studied females. 
WC and WHR exhibited highly significant inverse correlation with all 
pulmonary function measurements except FEV1/FVC%; however, BMI 
had no significant correlation with any spirometric variables in obese 
females, suggesting that central obesity has more impact on impairment 
of dynamic lung function than overall relative obesity. However, random 
clinical trials must be conducted with the objective of identifying the 
repercussions of overweight for lung function. Consequently, it is 
necessary to implement health-care programs for this population, with 
the purpose of improving lung function and therefore improving the 
quality of life of obese individuals.
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